ZA200201819B - Preventive and therapeutic agents for eye diseases. - Google Patents

Preventive and therapeutic agents for eye diseases.

Info

Publication number
ZA200201819B
ZA200201819B ZA200201819A ZA200201819A ZA200201819B ZA 200201819 B ZA200201819 B ZA 200201819B ZA 200201819 A ZA200201819 A ZA 200201819A ZA 200201819 A ZA200201819 A ZA 200201819A ZA 200201819 B ZA200201819 B ZA 200201819B
Authority
ZA
South Africa
Prior art keywords
preventive
therapeutic agents
eye diseases
diseases
eye
Prior art date
Application number
ZA200201819A
Other languages
English (en)
Inventor
Hiroaki Naka
Kazuhito Kawabata
Hideki Tokushige
Original Assignee
Ono Pharmaceutical Co
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co, Senju Pharma Co filed Critical Ono Pharmaceutical Co
Publication of ZA200201819B publication Critical patent/ZA200201819B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200201819A 1999-09-06 2002-03-05 Preventive and therapeutic agents for eye diseases. ZA200201819B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25153899 1999-09-06

Publications (1)

Publication Number Publication Date
ZA200201819B true ZA200201819B (en) 2003-05-28

Family

ID=17224318

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201819A ZA200201819B (en) 1999-09-06 2002-03-05 Preventive and therapeutic agents for eye diseases.

Country Status (14)

Country Link
US (1) US6624193B1 (xx)
EP (1) EP1213018A4 (xx)
JP (1) JP4682495B2 (xx)
KR (1) KR20020042667A (xx)
CN (1) CN1387436A (xx)
AU (1) AU6870800A (xx)
BR (1) BR0013793A (xx)
CA (1) CA2383971A1 (xx)
HU (1) HUP0202745A2 (xx)
MX (1) MXPA02002452A (xx)
NO (1) NO20021094L (xx)
NZ (1) NZ517556A (xx)
WO (1) WO2001017527A1 (xx)
ZA (1) ZA200201819B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552082B2 (en) * 2000-06-29 2003-04-22 Ono Pharmaceutical Co., Ltd. Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
AU2001278779A1 (en) * 2000-08-25 2002-03-04 Senju Pharmaceutical Co. Ltd. Aqueous suspension preparations
US7315848B2 (en) * 2001-12-12 2008-01-01 Aaron Pearse Web snippets capture, storage and retrieval system and method
CN100341498C (zh) 2003-01-21 2007-10-10 千寿制药株式会社 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水成液制剂
WO2004064817A1 (ja) * 2003-01-22 2004-08-05 Nichiban Co., Ltd. 眼疾患治療用経皮吸収型製剤、その使用、及び眼疾患治療薬の眼の局所組織への移行方法
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
CA2597525A1 (en) * 2005-02-17 2006-08-24 Senju Pharmaceutical Co., Ltd. Solid ophthalmic drug for external use
AR059928A1 (es) 2006-09-29 2008-05-07 Johnson & Johnson Vision Care Metodos y dispositivos oftalmicos usados en el tratamiento de alergias oculares
CA2685230C (en) * 2007-05-04 2012-10-16 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
KR20100016285A (ko) * 2007-05-07 2010-02-12 보오슈 앤드 롬 인코포레이팃드 안구건조 상태를 감소, 개선, 치료 또는 예방하기 위한 조성물 및 이의 제조 및 사용 방법
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
US20100226992A1 (en) * 2009-03-03 2010-09-09 Alcon Research, Ltd. Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
CN111789814B (zh) 2013-03-14 2022-07-19 帕恩欧普佳有限公司 给药于眼后段的眼用制剂
US10383885B2 (en) 2015-06-16 2019-08-20 Rong-Tsun Wu Method for treating or preventing dry eyes
WO2019005222A1 (en) * 2017-06-29 2019-01-03 Advaite LLC. TREATMENT AND DIAGNOSIS OF OCULAR SURFACE DISORDERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017610A (en) * 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
JPH0320253A (ja) * 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸 p―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
EP0396709A4 (en) * 1988-10-27 1991-05-22 University Of Kentucky Research Foundation Human leukocyte elastase inhibitors and methods of producing and using same
ES2111013T3 (es) 1991-06-18 1998-03-01 Fujisawa Pharmaceutical Co Una composicion profilactica/terapeutica que contiene ws7622a para evitar o tratar la coagulacion intravascular diseminada, la enfermedad infecciosa cronica del tracto respiratorio o la bronquitis cronica.
GB9115811D0 (en) 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof
JPH05194366A (ja) * 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・4水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
CA2081268A1 (en) * 1991-10-25 1993-04-26 Katsuhiro Imaki Glycine derivative monosodium salt tetrahydrate

Also Published As

Publication number Publication date
AU6870800A (en) 2001-04-10
EP1213018A4 (en) 2004-04-14
CA2383971A1 (en) 2001-03-15
NZ517556A (en) 2003-08-29
HUP0202745A2 (hu) 2003-01-28
NO20021094D0 (no) 2002-03-05
US6624193B1 (en) 2003-09-23
EP1213018A1 (en) 2002-06-12
BR0013793A (pt) 2002-05-14
MXPA02002452A (es) 2004-09-10
CN1387436A (zh) 2002-12-25
WO2001017527A9 (en) 2001-06-21
KR20020042667A (ko) 2002-06-05
NO20021094L (no) 2002-05-06
WO2001017527A1 (fr) 2001-03-15
JP4682495B2 (ja) 2011-05-11

Similar Documents

Publication Publication Date Title
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
ZA200201819B (en) Preventive and therapeutic agents for eye diseases.
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
HK1040184A1 (zh) 治療青光眼之組合療法
GB9911881D0 (en) Therapeutic agents
GB9921351D0 (en) Therapeutic agents
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
PL339848A1 (en) Therapeutic agent against hypephosphataemia
GB9929569D0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9914744D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
ZA200110046B (en) Therapeutic agents.
GB9914745D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
PL352681A1 (en) Preventive and therapeutic agents for cancer
EP0925791A4 (en) PREVENTIVE AND / OR THERAPEUTICALLY ACTIVE SUBSTANCE FOR KIDNEY DISEASES
GB9914743D0 (en) Therapeutic agents
GB9915616D0 (en) Therapeutic agents
AU2001230589A1 (en) Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases